Protein kinase D3 sensitizes RAF inhibitor RAF265 in melanoma cells by preventing reactivation of MAPK signaling.

Saved in:
Bibliographic Details
Title: Protein kinase D3 sensitizes RAF inhibitor RAF265 in melanoma cells by preventing reactivation of MAPK signaling.
Authors: Chen J; Department of Developmental and Molecular Pathways, Novartis Institute for BioMedical Research, Inc., Cambridge, Massachusetts 02139, USA. jian.chen@novartis.com, Shen Q, Labow M, Gaither LA
Source: Cancer research [Cancer Res] 2011 Jun 15; Vol. 71 (12), pp. 4280-91. Date of Electronic Publication: 2011 Apr 28.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-10-3761